Boehringer Ingelheim Animal Health Usa Inc.
Boehringer Ingelheim Animal Health USA Inc., a prominent subsidiary of the global pharmaceutical company Boehringer Ingelheim, is headquartered in the United States. Established in 1885, the company has evolved into a leader in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence across North America, Boehringer Ingelheim Animal Health is renowned for its comprehensive portfolio of vaccines, pharmaceuticals, and diagnostic tools that enhance animal welfare and productivity. The company’s commitment to research and development has led to significant milestones, including advancements in vaccine technology and parasiticides. Boehringer Ingelheim Animal Health is recognised for its unique approach to animal care, combining scientific expertise with a deep understanding of animal health needs. As a key player in the market, the company continues to achieve notable success, reinforcing its position as a trusted partner in animal health.
DitchCarbon Score
How does Boehringer Ingelheim Animal Health Usa Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boehringer Ingelheim Animal Health Usa Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boehringer Ingelheim Animal Health USA Inc. currently does not have specific carbon emissions data available, as indicated by the absence of reported emissions figures. The company is a current subsidiary of Boehringer Ingelheim, and any potential emissions data or climate commitments may be cascaded from its parent organisation. However, there are no documented reduction targets or climate pledges outlined for Boehringer Ingelheim Animal Health USA Inc. at this time. As a part of the broader industry context, many companies are increasingly focusing on sustainability and climate action, often setting science-based targets to reduce their carbon footprints. While specific initiatives or commitments from Boehringer Ingelheim Animal Health USA Inc. are not detailed, the parent company may have overarching strategies that influence its subsidiaries. In summary, without specific emissions data or reduction targets, Boehringer Ingelheim Animal Health USA Inc. appears to be in the early stages of formalising its climate commitments within the framework of its parent company's sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Boehringer Ingelheim Animal Health Usa Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
